Advanced Basal Cell Carcinoma: How to Navigate Challenging Clinical Scenarios With Systemic Treatment
| Overview / Abstract: |
Join Karl Lewis, MD, and Aleksandar Sekulic, MD, PhD, as they discuss the importance of the hedgehog pathway in the pathogenesis of BCC and the role of hedgehog inhibitors in advanced BCC. Evidence related to the safety and efficacy of the approved hedgehog inhibitors sonidegib and vismodegib are discussed, with recommendations for optimizing their use. Case studies are utilized to share the faculty’s experience in treating patients with hedgehog inhibitors, including strategies to manage resistance. |
|
Expiration |
Feb 17, 2022 |
|
Discipline(s) |
Physician CME, Surgical Technology CE |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
|
Accreditation |
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
|
Presenters / Authors / Faculty |
Aleksandar Sekulic, MD, PhD Karl D. Lewis, MD |
|
Activity Specialities / Related Topics |
Dermatology, Oncology / Cancer / Radiation Therapy |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme. |
|
Keywords / Search Terms |
Annenberg Center for Health Sciences at Eisenhower Basel Cell Carcinoma Carcinoma Skin Cancer Mohs Surgery Hedgehog Pathway Pathogenesis of BCC BCC Free CE CME |
|